Vnitr Lek 2014, 60(12):1068-1071

Obesity and heart

Štěpán Svačina
III. interní klinika 1. LF UK a VFN Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA

Cardiovascular complications of obesity are traditionally considered an important complication of obesity. Obesity itself is probably not direct cause of atherosclerosis or coronary heart disease. This may occur indirectly in metabolic complications of obesity, especially diabetes and metabolic syndrome. However, thrombogenicity potential of obesity contributes to embolism and atherosclerosis development. In cardiology is well-known a phenomenon of obesity paradox when obese patients have better prognosis than thin. This is the case of heart failure and some other cardiovascular diseases. Recently, a new concept has emerged of myokines - hormones from muscle tissue that have extensive protective effects on organism and probably on heart. Whether heart is a source of myokines is uncertain. However, undoubted importance has epicardial and pericardial fatty tissue. The epicardial fatty tissue has mainly protective effects on myocardium. This fatty tissue may produce factors of inflammation affecting the myocardium. Relationship between amount of epicardial fatty tissue and coronary heart disease is rather pathogenic. Currently, it is certain that obesity brings more metabolic and cancer complications than cardiovascular and accurate contribution to pathogenic or protective character of fatty tissue in cardiology requires further research. Nevertheless, the conclusion is that adipose tissue of organism and around the heart may be in some circumstances beneficial.

Keywords: adipokines; complications of obesity; epicaridal fatty tissue; myokines; obesity paradox; pericardial fatty tissue

Received: November 2, 2014; Accepted: November 13, 2014; Published: December 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Svačina Š. Obesity and heart. Vnitr Lek. 2014;60(12):1068-1071.
Download citation

References

  1. Ardestani A, Hoffman HJ, Cooper HA. Obesity and outcomes among patients with established atrial fibrillation. Am J Cardiol 2010; 106(3): 369-373. Go to original source... Go to PubMed...
  2. Artham SM, Lavie CJ, Milani RV et al. Obesity and hypertension, heart failure, and coronary heart disease-risk factor, paradox, and recommendations for weight loss. Ochsner J 2009; 9(3):124-132. Go to PubMed...
  3. Cherian S, Lopaschuk GD, Carvalho E. Cellular cross-talk between epicardial adipose tissue and myocardium in relation to the pathogenesis of cardiovascular disease. Am J Physiol Endocrinol Metab 2012; 303(8): E937-E949. Go to original source... Go to PubMed...
  4. Isomaa B, Almgren P, Tuomi T et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24(4): 683-689. Go to original source... Go to PubMed...
  5. Jee SH, Sull JW, Park J et al. Body-mass index and mortality in Korean men and women. N Engl J Med 2006; 355(8): 779-787. Go to original source... Go to PubMed...
  6. Kim TH, Park J, Park JK et al. Pericardial fat volume is associated with clinical recurrence after catheter ablation for persistent atrial fibrillation, but not paroxysmal atrial fibrillation: An analysis of over 600-patients. Int J Cardiol 2014; 176(3): 841-846. Go to original source... Go to PubMed...
  7. Lainscak M, von Haehling S, Doehner W et al. The obesity paradox in chronic disease: facts and numbers. J Cachexia Sarcopenia Muscle 2012; 3(1): 1-4. Go to original source... Go to PubMed...
  8. Mahabadi AA, Lehmann N, Kälsch H et al. Association of epicardial adipose tissue with progression of coronary artery calcification is more pronounced in the early phase of atherosclerosis: results from the Heinz Nixdorf recall study. JACC Cardiovasc Imaging 2014; 7(9): 909-916. Go to original source... Go to PubMed...
  9. Pedersen BK. Muscle as a secretory organ. Compr Physiol 2013; 3(3): 1337-1362. Go to original source... Go to PubMed...
  10. Reis JP, Allen N, Gibbs BB et al. Association of the degree of adiposity and duration of obesity with measures of cardiac structure and function: The CARDIA Study. Obesity (Silver Spring) 2014; 22(11):2434-2440. Go to original source... Go to PubMed...
  11. Roberts LD, Boström P, O'Sullivan JF et al. β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors. Cell Metab 2014; 19(1): 96-108. Go to original source... Go to PubMed...
  12. Shaw KA, Edelman AB. Obesity and oral contraceptives. Best Pract Res Clin Endocrinol Metab 2013; 27(1): 55-65. Go to original source... Go to PubMed...
  13. Svačina Š. Obezitologie a teorie metabolického syndromu. Triton: Praha 2013. ISBN 978-80-7387-678-4.
  14. Walsh K. Adipokines, myokines and cardiovascular disease. Circ J 2009; 73(1): 13-18. Go to original source... Go to PubMed...
  15. Yamada H, Sata M. The role of pericardial fat: The good, the bad and the ugly. J Cardiol 2014; pii S0914-5087(14)00203-2. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jjcc.2014.07.004>. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.